From reflux to esophageal cancer. Josh Boys, MD TCV 2 nd year indentured servant
|
|
- Audra Thornton
- 5 years ago
- Views:
Transcription
1 From reflux to esophageal cancer Josh Boys, MD TCV 2 nd year indentured servant
2
3 The Pathway Esophageal Squamous epithelium+reflux Columnar lined esophagus (CLE) or Cardiac mucosa Intestinal Metaplasia or Barrett s Esophagus (BE) BE+Dysplasia Esophageal Adenocarcinoma
4 The Players in the Game Esophagus Squamous epithelium Motility Cardia Cardiac mucosa (no parietal cells)? Oxyntocardiac mucosa (parietal cells) LES Fundus/Body/Antrum Chief cells (pepsinogen) Parietal cells (HCL and IF) G cells (Gastrin) Human Gastric Anatomy, MIT
5 Is the Cardiac mucosa normal or abnormal? Chandrasoma et al Autopsy study of the GEJ Pure cardiac mucosa was absent in 56% of patients All patients had oxyntocardiac mucosa (mucus and parietal cells) The measured maximum length of cardiac plus oxyntocardiac musoa was less than 0.5cm in 76% There was a tendency for the presence and extent of cardiac mucosa to increase with age Conclusion: cardiac mucosa is not a normal structure (controversial) Kilgore et al Autopsy study in a pediatric population 100% of cases had cardiac type mucosa w/ a mean length of 1.8mm
6 Reflux and the Danger Zone
7 Gastroesophageal Reflux Disease (GERD) Increased or abnormal exposure of the esophageal mucosa to refluxed gastric juice AKA
8 DeMeester and Ireland 1997 Dis Esoph Esophageal Epithelial Damage Distance by Exposure Correlation between acid exposure and length of cardiactype columnar epithelium
9 ph and Mucosal Injury Bremner et al Prevalence of mucosal injury Bremner et al. 1992
10 How bile makes it happen Side note: Normal volunteers taking 20mg omeprazole BID Spend 30% of 24hrs with A gastric ph < 4 Kuo and Castell 1996 Am J Gastro DeMeester 2000 ann surg
11 Kauer et al Bilirubin and Mucosal Injury
12 ph and the nature of refluxed material is critical in the distribution of intestinal metaplasia within a CLE Modulates stem cells? Alters expression of genes? i.e. Wnt, BMP-4, hedgehog and Cdx-2 Imamura et al. 2015
13 Among patients with Barrett s Bile exposure increases the risks of complications dysplasia Oberg et al J Gastrointest Surg
14 Patients who have the most mucosal injury have both gastroduodenal and acid reflux as opposed to pure gastric reflux
15 Barrett s Esophagus
16 What exactly is Barrett s esophagus? I know it when I see it
17 Where does Barrett s (intestinal metaplasia) come from?
18 How does Barrett s (intestinal metaplasia) happen? Squamous epithelial cell Circulating Bone Marrow stem cell Squamocolumnar Submucosal junction cell gland cell (Cardiac mucosa) Four Horsemen of the Apocalypse, an 1887 painting by Viktor Vasnetsov. Depicted from left to right are Death, Famine, War, and Conquest.
19 Circulating Bone Marrow Stem Cell
20 Esophageal Squamous epithelium to Barrett s It s complicated and not completely known It s likely at least a 2 step process Step 1: Trasndifferentiation of squamous to columnar cells Step 2: Development of Barrett s (intestinal metaplasia w/ goblet cells)
21 Step 2: Barrett s Esophagus Related to: Nature of refluxed gastric juice bile is important Correlated to the length of columnar lining Location of the IM is not random Campos et al. 2001
22 Location, Location Location Paull et al NEJM Systematic histology of 11 patients with columnar lined esophagus Biopsies obtained from the lower esophageal sphincter and then at interval of 1-3cm into the body of the esophagus IM was always proximal
23 Is all Barrett s equal? Fitzgerald et. al Gut 26 patients w/ BE > 3cm (IL-10) 20 non-dysplastic BE 6 HGD/carcinoma (4/6 w/ distal Ca) Assessed inflammatory markers along length of BE from cell culture IL-1 IL-8 IL-10 Inflammatory gradient w/ maximal inflammation at the new SCJ Distal BE segment is characterized by a relatively non-inflamed epithelium w/ assoc high levels of IL-10
24 Locaction, Location, Location cont The hallmark feature of intestinal metaplasia = Goblet cells The highest density is also at the proximal columnar segment Biopsies for Barrett s should be focused near the squamocolumnar junction Chandrasoma et al. 2001
25 Incidence of BE? Tough to know, but somewhere between 0.45% to 3.3% of all patients undergoing EGD 12% of patients undergoing EGD for GERD 3-6% with long segment BE Autopsy series (Cameron et al Gastroenterology) 7 cases out of 733 unselected autopsies 5/7 (70%) were first detected at autopsy Estimate 376 cases per 100,000 population For every known patient with Barrett s, there might be 20 or more unrecognized one in the general population
26 Screening for BE ACG and AGA Consider in men with > 5 years and/or frequent symptoms of GERD and two or more risk factors for BE or EAC. Age > 50 Caucasian Central obesity Current or past history of smoking Confirmed family history of BE or EAC
27 Screening/Surveillance of BE We screen and do surveillance of people at risk or who have Barrett s esophagus (intestinal metaplasia) because we want to catch dysplasia and esophageal adenocarcinoma early
28 Why is finding esophageal cancer early important?
29
30 RR 0.60, 95% CI in esophageal adenocarcinoma mortality
31 Secondary outcomes Overall mortality was associated with a 25% reduction in mortality HR 0.75; 95% CI Patients under BE surveillance were more likely to be diagnosed with early stag (stage 0 or stage I) RR 2.11; 95% CI There was no difference between the two groups with regard to receipt of esophagectomy
32 What are the chances? Chandrasoma et al. Am J Surg Pathol cm CLE = 70% chance of BE 3-4cm CLE = 89.5% chance of BE 5 cm CLE = 100% chance of BE Current biopsy protocol 4 quadrant biopsy every 1-2cm of BE Can miss 10-50% of esophageal neoplasms
33 New Techniques for BE, Dysplasia and EAC
34 The Current modes High-definition white light and narrow band imaging Neither allow reliable determination of the presence of intestinal metaplasia or dysplasia within CLE Require biopsies and histological evaluation Without irregular features in the columnar mucosa, biopsies are obtained at random May miss dysplasia or early adenocarcinoma Biopsies take days to process and be read by pathologist
35 Probe-based confocal laser endomicroscopy Confocal endomicroscopy to be used via probes passed down the working channel Real-time assessment of cellular and subcellular architecture within tissue Fixed focal length Depth µm Resolution 1 µm (single RBC) Used in combo w/ IV fluorescein to increase imaging depth (optimal time is 10 min after injection) Distinguish between different epithelial cells and detect dysplasia/neoplasia
36 Miami Criteria (Caillol et al. 2017)
37 Zihni and DeMeester Thor Surg Clin 2018 Squamous Mucosa recognized as light gray, flat, scale like cells Oxyntic gastric mucosa with gastric Pits are round, regular, dark circles
38 Zihni and DeMeester Thor Surg Clin 2018 CLE columnar epithelium w/ regularly spaced glands and cells. Dark Goblet Cells are absent. BE w/ CLE w/ addition of dark round goblet cells. Glands are regular and organized
39 Non dysplastic BE BE with early esophageal Adenocarcinoma
40 P-CLE Evidence Sharma et al Gastroint Endo Prospective RCT 101 BE patient for surveillance or treatment for HGD/EC Bx by HD-WLE/NBI and 4 quadrant random biopsies Bx sites examined by pcle and presumptive dx of tissue was made Blinded pathologist to endocscopic and pcle data Identified an additional 41 areas of HGD-EAC in subjects when lesions visible by WLE were excluded
41 pcle compared to random biopsies during BE surveillance Shah et al endosc Int open Retrospective study pcle identified all cases of EAC in 55 subjects Sensitivity of 67% and specificity of 98% PPV of 67% for HGD-EAC The sensitivity of LGD was low compared to random biopsies Good for real-time use to confirm HGD and EAC, but incremental benefit over WLE/NBI
42 pcle meta-analysis 14 studies, 789 patients, 4047 lesions Per patient Sensitivity 89% Specificity 83% Per lesion Sensitivity 77% Specificity 89% Conclusion: CLE can accurately differentiate neoplasms from nonneoplasms in BE Xiong et al J Gastrentr and hepatol
43 Optical Coherence Tomography and Volumetric Laser Endomicroscopy Optical ultrasonography in which reflected infrared light waves (no sound waves) are used to obtain subsurface, cross-sectional images of mucosal surface Can show mucosal and submucosal structures in microscopic detail The level of detail comes at the price of limited depth Standard endoscope with balloon centered prob Scans 6cm esophagus in 90 seconds Depth of 3mm Manual controller to tag areas of biopsy
44
45 Zihni and DeMeester Thor Surg Clin 2018 Squamous mucos on OCT. Uniform layering of esophageal wall. Mucosa, submucosa and 2 layers of the muscularis propria
46 CLE: indicated by loss of normal layering pattern. Mucosa, submucosa and muscularis propria layers are indistinct Dysplasia and cancer by dark appearance to the superficial layers and glandular structures in the subserface layers
47 OCT scoring index: A score > 2 is associated with a sensitivity of 83% and specificity of 75% for dysplasia Trindade and Smith 2016 Ther Adv Gastroenterol
48 Clinical application of VLE Competes with other technologies for screening, surveillance and mapping of BE, dysplasia and EAC NICHE: follow-up of patients after endoscopic resection or ablation therapy No other therapy can image below the neosquamous mucosa to detect buried residual BE glands
49 Swager et al Gastrointest Endosc 17 subjects treated to no visible BE HD-WLE showed no visible lesions VLE showed 1 or more area of subsquamous glandular structure in 13 (76%) The frequency of buried BE was 8%
50 Tsai et al 2012 Gastroint Endosc VLE to predict efficacy of ablation therapy based on the pretreatment thickness of the metaplastic or dysplastic mucosa BE eradication was significantly thinner (257 vs 403 microns) BE thickeness > 333 microns were more likely to have VLE detected residual glands immediately after RFA Se 92% and Sp of 85% They also had increased areas of persistent BE on follow up endoscopy Se 83% and Sp 95%
51 Swager et al Gastroint Endosc 52 EMR 86 VLEhistology matches
52 VLE Next Steps: Swager et al Gastroint Endosc Computer-aided detection of early Barrett s neoplasia using VLE 60 VLE images of ex-vivo VLE-histology correlations BE+/-neoplasia (30/30) Compared to VLE experts who scored the same ex-vivo VLE images the algorithm performed better AUC comparec to 0.81 for experts Tethered swallow capsule (12mm diameter) currently being tested
53 Wide Area Transepithelial Sampling with 3- Dimensional Analysis Brush throught the working channel Bristles are more rigid leading to a deeper tissue sample (lamina propria) Increased stiffness leads to accumulation of clumps of cells on the brush or microbiopsies Asses glandular architecture and therefore dysplasia Sample segmentn lengths up to 6cm with each brush 100,000 cells on each brush -> rolled over on a slide and tip is then placed in formalin for a cell block Second brush is used and placed directly in formalin for cell block Extended depth of field creates a single 3-d image to view the multilayerd sample for the pathologist Neural network-based algorithm identifies the 200 most suspicious cells or clusters
54 Gross et al UEG Non dysplastic BE EAC w/ nuclear pleomorphism, Hyperchromaisa, scant cytoplasm, Loss of cellular cohesion
55 WATS is an adjunct to standard 4 quadrant bx Gross et al united european gastroenterol J. Multicenter prospective trial (25 community based practices) Patients screened for suspected BE and those w/ known BE for surveillance 4204 patients BE 594 cases diagnosed BE with forceps biopsy 493 additional cases were detected using WATS (83% increase) LGD 26 cases by forceps biopsy 23 additional cases by WATS (88% increase)
Volumetric laser endomicroscopy can target neoplasia not detected by conventional endoscopic measures in long segment Barrett s esophagus
E318 Volumetric laser endomicroscopy can target neoplasia not detected by conventional endoscopic measures in long segment esophagus Authors Institution Arvind J. Trindade, Benley J. George, Joshua Berkowitz,
More informationManagement of Barrett s: From Imaging to Resection
Management of Barrett s: From Imaging to Resection Michael Wallace, MD, MPH, FACG Professor of Medicine Mayo Clinic Florida Goals of Endoscopic Evaluation in Barrett s Detect Barrett s and dysplasia Reduce/eliminate
More informationAmerican Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma
Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma Journal: Manuscript ID: AJG-13-1412.R1 Manuscript Type: Letter to the Editor Keywords: Barrett-s esophagus, Esophagus, Endoscopy
More informationBarrett s Esophagus: Old Dog, New Tricks
Barrett s Esophagus: Old Dog, New Tricks Stuart Jon Spechler, M.D. Chief, Division of Gastroenterology, VA North Texas Healthcare System; Co-Director, Esophageal Diseases Center, Professor of Medicine,
More informationNew Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus
New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus Prateek Sharma, MD Key Clinical Management Points: Endoscopic recognition of a columnar lined distal esophagus is crucial
More informationGland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful in characterizing esophageal location
Diseases of the Esophagus (2005) 18, 87 92 2005 ISDE Blackwell Publishing, Ltd. Original article Gland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful
More informationDefinition of GERD American College of Gastroenterology
Definition of GERD American College of Gastroenterology GERD is defined as chronic symptoms or mucosal damage produced by the abnormal reflux of gastric contents into the esophagus DeVault et al. Am J
More informationBarrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD?
Barrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD? Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina 1 Outline What are the risks of progression
More informationBarrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI
Barrett s Esophagus Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI A 58 year-old, obese white man has had heartburn for more than 20 years. He read a magazine
More informationHistopathology of Endoscopic Resection Specimens from Barrett's Esophagus
Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus Br J Surg 38 oct. 1950 Definition of Barrett's esophagus A change in the esophageal epithelium of any length that can be recognized
More informationAblation for Barrett s Esophagus: Burn or Freeze
Ablation for Barrett s Esophagus: Burn or Freeze John R. Saltzman MD Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School Disclosures No relevant disclosures
More informationJoel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery
Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery Norman Barrett (1950) described the esophagus as: that part of the foregut, distal to the cricopharyngeal sphincter, which is lined
More informationBarrett s esophagus. Barrett s neoplasia treatment trends
Options for endoscopic treatment of Barrett s esophagus Patrick S. Yachimski, MD MPH Director of Pancreatobiliary Endoscopy Assistant Professor of Medicine Division of Gastroenterology, Hepatology & Nutrition
More informationLearning Objectives:
Crescent City GI Update 2018 Ochsner Clinic, NOLA Optimizing Endoscopic Evaluation of Barrett s Esophagus What Should I Do in My Practice? Gregory G. Ginsberg, M.D. Professor of Medicine University of
More informationGregory G. Ginsberg, M.D.
Radiofrequency Ablation for Barrett s Esophagus with HGD Gregory G. Ginsberg, M.D. Professor of Medicine University of Pennsylvania School of Medicine Abramson Cancer Center Gastroenterology Division Executive
More informationPresent Day Management of Barrett s Esophagus
Slide 1 Present Day Management of Barrett s Esophagus Kinnari R. Kher, M.D. Slide 2 Goals Risk factors for development of Barrett s esophagus Risks for progression to Esophageal Adenocarcinoma Current
More informationMANAGEMENT OF BARRETT S RELATED NEOPLASIA IN 2018
MANAGEMENT OF BARRETT S RELATED NEOPLASIA IN 2018 Sachin Wani Medical Director Esophageal and Gastric Center Division of Gastroenterology and Hepatology University of Colorado Anschutz Medical Campus DISCLOSURES
More informationRFA and Cyrotherapy for Esophageal Disease
RFA and Cyrotherapy for Esophageal Disease Daniel L. Miller MD Chief, General Thoracic Surgery WellStar Healthcare System/ Mayo Clinic Care Network Clinical Professor of Surgery Medical College of Georgia/
More informationBarrett's Esophagus: Sorting Out the Controversy
Barrett's Esophagus: Sorting Out the Controversy Learning Objectives 1. Identify the challenges in screening for Barrett s esophagus 2. Demonstrate comprehension of the risk of progression of Barrett s
More informationHistory. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management
Barrett s Esophagus: Controversy and Management History Norman Barrett (1950) Chronic Peptic Ulcer of the Oesophagus and Oesophagitis Allison and Johnstone (1953) The Oesophagus Lined with Gastric Mucous
More informationIs intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?
Diseases of the Esophagus (2007) 20, 36 41 DOI: 10.1111/j.1442-2050.2007.00638.x Blackwell Publishing Asia Original article Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of
More informationAGA SECTION. Gastroenterology 2016;150:
Gastroenterology 2016;150:1026 1030 April 2016 AGA Section 1027 Procedural intervention (3) Upper endoscopy indications 3 6 Non-response of symptoms to a 4 8 week empiric trial of twice-daily PPI Troublesome
More informationGastrooesophageal reflux disease. Jera Jeruc Institute of pathology, Faculty of Medicine, Ljubljana, Slovenia
Gastrooesophageal reflux disease Jera Jeruc Institute of pathology, Faculty of Medicine, Ljubljana, Slovenia Reflux esophagitis (RE) GERD: a spectrum of clinical conditions and histologic alterations resulting
More informationEvaluating Treatments of Barrett s Esophagus That Shows High-Grade Dysplasia
...PRESENTATIONS... Evaluating Treatments of Barrett s Esophagus That Shows High-Grade Dysplasia Based on a presentation by Bergein F. Overholt, MD Presentation Summary Thermal ablation and surgery are
More informationOesophagus and Stomach update dysplasia and early cancer
Oesophagus and Stomach update dysplasia and early cancer Dr Tim Bracey STR teaching 13/4/16 Please check pathkids.com for previous talks One of the biggest units in the country (100 major resections per
More informationCurrent Management: Role of Radiofrequency Ablation
Esophageal Adenocarcinoma And Barrett s Esophagus: Current Management: Role of Radiofrequency Ablation Ketan Kulkarni, MD Regional Gastroenterology Associates of Lancaster INTRODUCTION The prognosis of
More informationBarrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ
Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ Table of contents 1 General project information...3 1.1 Inclusion criteria...3 1.2 Registration time points...3 1.3 Project variable
More informationACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus
ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus Nicholas J. Shaheen, MD, MPH, FACG 1, Gary W. Falk, MD, MS, FACG 2, Prasad G. Iyer, MD, MSc, FACG 3 and Lauren Gerson, MD, MSc, FACG
More informationBarrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions
Barrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions Robert Odze, MD, FRCPC Chief, Gastrointestinal Pathology Associate Professor of Pathology Brigham and Women s Hospital Harvard
More informationManagement of Barrett s Esophagus. Case Presentation
Management of Barrett s Esophagus Lauren B. Gerson MD, MSc Associate Clinical Professor, UCSF Director of Clinical Research Gastroenterology Fellowship Program California Pacific Medical Center San Francisco,
More informationThe Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin
The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin 24.06.15 Norman Barrett Smiles [A brief digression - Chair becoming
More informationBurning Issues in the Esophagus
Burning Issues in the Esophagus Elizabeth Montgomery, MD Johns Hopkins Medical Institutions Dr. Montgomery reports no relevant financial relationships with commercial interests. Squamous Epithelium Muscularis
More informationHenry Moon was one of the giants in academic pathology during my early years.
Henry Moon was one of the giants in academic pathology during my early years. Controversial stuff that occurs slightly above, within or slightly below the gastroesophageal junction, including Barrett s
More informationEndoscopic Management of Barrett s Esophagus
Endoscopic Management of Barrett s Esophagus Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center Barrett s Esophagus Consequence of chronic GERD Mean
More informationConfocal Laser Endomicroscopy
Confocal Laser Endomicroscopy Policy Number: 2.01.87 Last Review: 3/2018 Origination: 3/2013 Next Review: 9/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide coverage for
More informationNIH Public Access Author Manuscript Gastrointest Endosc. Author manuscript; available in PMC 2012 July 13.
NIH Public Access Author Manuscript Published in final edited form as: Gastrointest Endosc. 2012 July ; 76(1): 32 40. doi:10.1016/j.gie.2012.02.003. Characterization of buried glands before and after radiofrequency
More informationBarrett s Esophagus: Ablate Everyone?
Nicholas J. Shaheen, MD, MPH, FACG Barrett s Esophagus: Ablate Everyone? Nicholas J. Shaheen, MD, MPH, FACG Center for Esophageal Diseases and Swallowing University of North Carolina Greetings from UNC,
More informationAdenocarcinoma of the distal esophagus is a recognized
ORIGINAL ARTICLE Adenocarcinomas of the Distal Esophagus and Gastric Cardia Are Predominantly Esophageal Carcinomas Parakrama Chandrasoma, MD, Kumari Wickramasinghe, MD, PhD, Yanling Ma, MD, and Tom DeMeester,
More informationUniversity Mainz. Early Gastric Cancer. Ralf Kiesslich. Johannes Gutenberg University Mainz, Germany. Early Gastric Cancer 15.6.
Ralf Kiesslich Johannes Gutenberg University Mainz, Germany DIAGNOSIS Unmask lesions - Chromoendoscopy -NBI Red flag technology - Autofluorescence Surface and detail analysis - Magnifying endoscopy - High
More informationChanges to the diagnosis and management of Barrett s Oesophagus
Changes to the diagnosis and management of Barrett s Oesophagus A review of the new BSG and NICE guidelines and best practice Anjan Dhar DM, MD, FRCPE, AGAF, MBBS (Hons.), Cert. Med. Ed Senior Lecturer
More informationWhat s New in the Management of Esophageal Disease
What s New in the Management of Esophageal Disease Philip O. Katz, MD Chairman, Division of Gastroenterology Einstein Medical Center Philadelphia Clinical Professor of Medicine Jefferson Medical College
More informationTreat Barrett s, Remove the Risk. HALO System
Treat Barrett s, Remove the Risk HALO System The HALO 360 System Advanced Ablation Technology for Barrett s Esophagus The HALO 360 System is designed to remove the Barrett s epithelium in a short, well-tolerated
More informationQuiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False
Quiz 1 1. Which of the following are risk factors for esophagus cancer. a. Obesity b. Gastroesophageal reflux c. Smoking and Alcohol d. All of the above 2. Adenocarcinoma of the distal stomach has been
More informationIn 1998, the American College of Gastroenterology issued ALIMENTARY TRACT
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:1232 1236 ALIMENTARY TRACT Effects of Dropping the Requirement for Goblet Cells From the Diagnosis of Barrett s Esophagus MARIA WESTERHOFF,* LINDSEY HOVAN,
More informationVital staining and Barrett s esophagus
Marcia Irene Canto, MD, MHS Baltimore, Maryland Vital staining or chromoendoscopy refers to staining of endoscopic tissue or topical application of chemical stains or pigments to alter tissue appearances
More informationHistological Features of Gastric Cardia in Adults: an Autopsy
original PAPERs Histological Features of Gastric Cardia in Adults: an Autopsy Study Zorica M. Stojsic 1, Radmila M. Stevanovic 1, Martina M. Stojanovic 1, Aleksandar D. Stanojevic 2, Dragoljub T. Bacetic
More informationChromoendoscopy and Endomicroscopy for detecting colonic dysplasia
Chromoendoscopy and Endomicroscopy for detecting colonic dysplasia Ralf Kiesslich I. Medical Department Johannes Gutenberg University Mainz, Germany Cumulative cancer risk in ulcerative colitis 0.5-1.0%
More informationPatterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett s esophagus
Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett s esophagus Robert J. Korst, MD, a,b Sobeida Santana-Joseph, MSN, a,b John R. Rutledge, MAS,
More informationFaculty Disclosure. Objectives. State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) 24/11/2014
State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) Dr. Amy Morse November 2014 Faculty: Amy Morse Faculty Disclosure Relationships with commercial interests: Grants/Research
More informationBarrett s Esophagus. Radiofrequency Ablation with the HALO Technology A Reference Book
Radiofrequency Ablation with the HALO Technology A Reference Book 540 Oakmead Parkway, Sunnyvale, CA 94085 What is Barrett s esophagus? Barrett s esophagus is a change that occurs within the cellular lining
More informationBarrett esophagus. Bible class Inselspital
Barrett esophagus Bible class Inselspital 2015.08.10 Guidelines Definition? BSG: ACG: Definition? BSG: ACG: What are the arguments for and against IM as prerequisite for the Dg? What are the arguments
More informationDisclosures. Gastroesophageal Reflux Disease. Gastroesophageal Reflux Disease
Kunal Jajoo, MD Brigham and Women s Hospital July 2012 Disclosures Spouse is a physician employed by Boston Scientific Corporation The content of this lecture equitably discusses products of multiple companies
More informationIdentifying Intestinal Metaplasia at the Squamocolumnar Junction by Using Optical Coherence Tomography
Identifying Intestinal Metaplasia at the Squamocolumnar Junction by Using Optical Coherence Tomography The Harvard community has made this article openly available. Please share how this access benefits
More information(b) Stomach s function 1. Dilution of food materials 2. Acidification of food (absorption of dietary Fe in small intestine) 3. Partial chemical digest
(1) General features a) Stomach is widened portion of gut-tube: between tubular and spherical; Note arranged of smooth muscle tissue in muscularis externa. 1 (b) Stomach s function 1. Dilution of food
More informationThe Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
Real-Time Increased Detection of Neoplastic Tissue in Barrett s Esophagus with Probe-Based Confocal Laser Endomicroscopy: Final Results of an International Multicenter, Prospective, Randomized, Controlled
More informationSixteen-year follow-up of Barrett s esophagus, endoscopically treated with argon plasma coagulation
Original Article Sixteen-year of Barrett s esophagus, endoscopically treated with argon plasma coagulation United European Gastroenterology Journal 2014, Vol. 2(5) 367 373! Author(s) 2014 Reprints and
More informationBarrett s Esophagus. lining of the lower esophagus that bears his name (i.e., Barrett's esophagus). We now
Shamika Johnson Anatomy & Physiology 206 April 20, 2010 Barrett s Esophagus What is Barrett s Esophagus? Norman Barrett was a pathologist. In 1950, he described an abnormality in the lining of the lower
More informationMedicare Advantage Medical Policy
Medicare Advantage Medical Policy Current Policy Effective Date: 1/1/18 Title: Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus Description/Background Barrett Esophagus and the
More informationSAM PROVIDER TOOLKIT
THE AMERICAN BOARD OF PATHOLOGY Maintenance of Certification (MOC) Program SAM PROVIDER TOOLKIT Developing Self-Assessment Modules (SAMs) www.abpath.org The American Board of Pathology (ABP) approves educational
More informationRecurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett s esophagus may not be benign
THIEME E849 Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett s esophagus may not be benign Authors Georgina R. Cameron 1, 3, Paul
More informationDivision of Anatomic Pathology & Molecular Oncology, University of Utah and ARUP Laboratories, Huntsman Cancer Institute, Salt Lake City, UT, USA
REVIEW ISSN 1738-3331, http://dx.doi.org/10.7704/kjhugr.2014.14.3.131 The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2014;14(3):131-162 Barrett s Esophagus Mary P. Bronner Division
More informationIs Radiofrequency Ablation Effective In Treating Barrett s Esophagus Patients with High-Grade Dysplasia?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 12-2016 Is Radiofrequency Ablation Effective
More informationRole of radiofrequency ablation in Barrett s esophagus
Review Article Page 1 of 7 Role of radiofrequency ablation in Barrett s esophagus Martin Riegler 1, Gerd Jomrich 2, Sebastian F. Schoppmann 2 1 Reflux Medical, Vienna, Austria; 2 Department of Surgery,
More informationEndoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus
Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus Policy Number: Original Effective Date: MM.02.005 09/01/2010 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration
More informationEverything Esophagus: Barrett s Esophagus. Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina
Everything Esophagus: Barrett s Esophagus Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina The Most Important Thing Stayed the Same Adenocarcinoma A
More informationRelative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia
Gut 2000;46:9 13 9 PAPERS Division of Gastroenterology, University of Kansas, VA Medical Center, Kansas City, Missouri, USA P Sharma A P Weston Department of Pathology, VA Medical Center, Kansas M Topalovski
More informationRadiofrequency Ablation: Stepwise circumferential and focal RFA of Barrett s s esophagus using the HALO System
Radiofrequency Ablation: Stepwise circumferential and focal RFA of Barrett s s esophagus using the HALO System Used abbreviations BE: Barrett s esophagus EC: Early cancer ER: Endoscopic resection HGD:
More informationBarrett s Esophagus: State of the Art Management
In the Name of God Barrett s Esophagus: State of the Art Management Siavosh Nasseri-Moghaddam MD, MPH, AGAF Associate Professor of Medicine Digestive Disease Research Center, Shariati Hospital, TUMS IAGH
More informationCDx Diagnostics THE NEW STANDARD FOR QUALITY GI CARE
CDx Diagnostics THE NEW STANDARD FOR QUALITY GI CARE STUDYDESIGN 16 major academic GI centers participated in a double-blind, randomized, crossover study in which 160 high-risk patients undergoing BE surveillance
More informationInflammation and Specialized Intestinal Metaplasia of Cardiac Mucosa Is a Manifestation of
ANNALS OF SURGERY Vol. 226, No. 4, 522-532 1997 Lippincott-Raven Publishers Inflammation and Specialized Intestinal Metaplasia of Cardiac Mucosa Is a Manifestation of Gastroesophageal Ref ux Disease Stefan
More informationEndoscopic Radiofrequency Ablation or Cryoablation for Barrett s Esophagus
Endoscopic Radiofrequency Ablation or Cryoablation for Barrett s Esophagus Policy Number: 2.01.80 Last Review: 6/2018 Origination: 6/2012 Next Review: 6/2019 Policy Blue Cross and Blue Shield of Kansas
More informationSpeaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015
GERD: Who and When to Treat Eugenio J Hernandez, MD Gastrohealth, PL Assistant Professor of Clinical Medicine, FIU Herbert Wertheim School of Medicine Speaker disclosure I do not have any relevant commercial
More informationQuality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care
Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage
More informationUpper Gastrointestinal Tract. Dr. Pascal Juillerat, M.Sc. epidemiology Gastroenterology, clinic for visceral surgery and medicine Inselspital, Bern
Upper Gastrointestinal Tract Dr. Pascal Juillerat, M.Sc. epidemiology Gastroenterology, clinic for visceral surgery and medicine Inselspital, Bern ? https://live.ueg.eu/week/app/ MONDAY Text GENETICS OR
More informationCitation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic management of Barrett s esophagus with dysplasia
UvA-DARE (Digital Academic Repository) Endoscopic management of Barrett s esophagus with dysplasia Phoa, Nadine Link to publication Citation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic
More informationDISCLOSURES. This program meets the requirements for GI specific Category 1 contact hours. M
DISCLOSURES Educational Dimensions is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center s Commission on Accreditation. Successful completion: Participants
More informationHow to characterize dysplastic lesions in IBD?
How to characterize dysplastic lesions in IBD? Name: Institution: Helmut Neumann, MD, PhD, FASGE University Medical Center Mainz What do we know? Patients with IBD carry an increased risk of developing
More informationQuality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care
Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process DESCRIPTION: Percentage
More informationScreening of Barrett: Is it cost-effective? Is there a high-risk population? T Ponchon Ed. Herriot Hospital Lyon, France
Screening of Barrett: Is it cost-effective? Is there a high-risk population? T Ponchon Ed. Herriot Hospital Lyon, France Barrett s esophagus (BE) is an acquired condition in which the normal squamous epithelium
More informationChapter 2 Complications of Gastroesophageal Reflux Disease
Chapter 2 Complications of Gastroesophageal Reflux Disease Patrick Yachimski Acute esophageal exposure to gastric and/or duodenal refluxate can result in pyrosis and symptomatic gastroesophageal reflux
More informationAlimentary Canal (I)
Alimentary Canal (I) Esophagus and Stomach (Objectives) By the end of this lecture, the student should be able to discuss the microscopic structure in correlation with the function of the following organs:
More informationEndoscopic Radiofrequency Ablation or Cryoablation for Barrett`s Esophagus. Original Policy Date
MP 2.01.52 Endoscopic Radiofrequency Ablation or Cryoablation for Barrett`s Esophagus Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature
More informationdiagnostics ISSN
Diagnostics 2014, 4, 57-93; doi:10.3390/diagnostics4020057 Review OPEN ACCESS diagnostics ISSN 2075-4418 www.mdpi.com/journal/diagnostics/ Endoscopic Optical Coherence Tomography for Clinical Gastroenterology
More informationMedical Policy. MP Confocal Laser Endomicroscopy
Medical Policy BCBSA Ref. Policy: 2.01.87 Last Review: 11/15/2018 Effective Date: 11/15/2018 Section: Medicine Related Policies 2.01.80 Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus
More informationAdvances in the Endoscopic Diagnosis of Barrett Esophagus
Special Report Advances in the Endoscopic Diagnosis of Barrett Esophagus Ashley H. Davis-Yadley, MD, Kevin G. Neill, MD, Mokenge P. Malafa, MD, and Luis R. Peña, MD Background: Barrett esophagus (BE) continues
More informationESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd
ESOPHAGEAL CANCER AND GERD Prof Salman Guraya FRCS, Masters MedEd Learning objectives Esophagus anatomy and physiology Esophageal cancer Causes, presentations of esophageal cancer Diagnosis and management
More informationCommon Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations
Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations Nicole C. Panarelli, M.D. Attending Pathologist Montefiore Medical Center Associate Professor of Pathology - Albert
More informationCitation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic management of Barrett s esophagus with dysplasia
UvA-DARE (Digital Academic Repository) Endoscopic management of Barrett s esophagus with dysplasia Phoa, Nadine Link to publication Citation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic
More informationPage 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis
Screening for Colorectal Neoplasia in Inflammatory Bowel Disease Francis A. Farraye MD, MSc Clinical Director, Section of Gastroenterology Co-Director, Center for Digestive Disorders Boston Medical Center
More informationSAMs Guidelines DEVELOPING SELF-ASSESSMENT MODULES TEST QUESTIONS. Ver. #
SAMs Guidelines DEVELOPING SELF-ASSESSMENT MODULES TEST Ver. #5-02.12.17 GUIDELINES FOR DEVELOPING SELF-ASSESSMENT MODULES TEST The USCAP is accredited by the American Board of Pathology (ABP) to offer
More informationMagnifying Endoscopy and Chromoendoscopy of the Upper Gastrointestinal Tract
Magnifying Endoscopy and Chromoendoscopy of the Upper Gastrointestinal Tract Alina M.Boeriu 1, Daniela E.Dobru 1, Simona Mocan 2 1) Department of Gastroenterology, University of Medicine and Pharmacy;
More informationHiatal Hernias and Barrett s esophagus. Dr Sajida Ahad Mercy General Surgery
Hiatal Hernias and Barrett s esophagus Dr Sajida Ahad Mercy General Surgery Objectives Identify the use of different diagnostic modalities for hiatal hernias List the different types of hiatal hernias
More informationBarrett s esophagus, reflux esophagitis, and eosinophilic esophagitis F. P. Vleggaar, P. D. Siersema Utrecht, the Netherlands
DDW HIGHLIGHTS F. P. Vleggaar, P. D. Siersema Utrecht, the Netherlands Many new and exciting endoscopy-related studies on Barrett s esophagus, reflux esophagitis, and eosinophilic esophagitis were presented
More informationWhat Is Barrett s Esophagus?
What Is Barrett s Esophagus? Having Barrett s esophagus means the cells lining the esophagus (the tube that links the mouth and the stomach) have changed into types of intestinal cells that are not normal
More informationAdvanced endoscopic imaging of esophageal neoplasia; old looks and new visions Boerwinkel, David
UvA-DARE (Digital Academic Repository) Advanced endoscopic imaging of esophageal neoplasia; old looks and new visions Boerwinkel, David Link to publication Citation for published version (APA): Boerwinkel,
More informationConfocal Laser Endomicroscopy of the Colon
clinical imaging Confocal Laser Endomicroscopy of the Colon Dan Ionut Gheonea, Adrian Saftoiu, Tudorel Ciurea, Carmen Popescu, Claudia Valentina Georgescu, Anca Malos Research Center of Gastroenterology
More informationThe normal esophagus is lined with squamous epithelium.
.. ALAN J. CAMERON, M.D. In Barrett's esophagus, the squamous lining of the lower esophagus is replaced by columnar epithelium. Barrett's esophagus is associated with gastroesophageal reflux and an increased
More informationSlide 1. Slide 2. Slide 3 DISCLOSURES EXPECTED OUTCOMES DIAGNOSIS AND TREATMENT
Slide 1 DIAGNOSIS AND TREATMENT 1 Slide 2 DISCLOSURES Successful completion: Participants must attend the entire program, including any resulting Q & A, and submit required documentation. Conflict of interest:
More informationAbout Omics Group conferences
About Omics Group OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 400 leading-edge
More informationBarrett s Esophagus: Are We Making any Progress?
3/22/217 arrett s Esophagus: re We Making any Progress? Stuart Jon Spechler, M.D. hief, Division of Gastroenterology, V North Texas Healthcare System; o-director, Esophageal Diseases enter, Professor of
More information